Abstract:IntroductionThe coronavirus disease 2019 (COVID-19) pandemic has affected billions of people worldwide, and the lessons learned need to be concluded to get better prepared for the next pandemic. Early identification of high-risk patients is important for appropriate treatment and distribution of medical resources. A generalizable and easy-to-use COVID-19 severity stratification model is vital and may provide references for clinicians.MethodsThree COVID-19 cohorts (one discovery cohort and two validation cohorts) were included. Longitudinal peripheral blood mononuclear cells were collected from the discovery cohort (n = 39, mild = 15, critical = 24). The immune characteristics of COVID-19 and critical COVID-19 were analyzed by comparison with those of healthy volunteers (n = 16) and patients with mild COVID-19 using mass cytometry by time of flight (CyTOF). Subsequently, machine learning models were developed based on immune signatures and the most valuable laboratory parameters that performed well in distinguishing mild from critical cases. Finally, single-cell RNA sequencing data from a published study (n = 43) and electronic health records from a prospective cohort study (n = 840) were used to verify the role of crucial clinical laboratory and immune signature parameters in the stratification of COVID-19 severity.ResultsPatients with COVID-19 were determined with disturbed glucose and tryptophan metabolism in two major innate immune clusters. Critical patients were further characterized by significant depletion of classical dendritic cells (cDCs), regulatory T cells (Tregs), and CD4+ central memory T cells (Tcm), along with increased systemic interleukin-6 (IL-6), interleukin-12 (IL-12), and lactate dehydrogenase (LDH). The machine learning models based on the level of cDCs and LDH showed great potential for predicting critical cases. The model performances in severity stratification were validated in two cohorts (AUC = 0.77 and 0.88, respectively) infected with different strains in different periods. The reference limits of cDCs and LDH as biomarkers for predicting critical COVID-19 were 1.2% and 270.5 U/L, respectively.ConclusionOverall, we developed and validated a generalizable and easy-to-use COVID-19 severity stratification model using machine learning algorithms. The level of cDCs and LDH will assist clinicians in making quick decisions during future pandemics.

Interpretable artificial intelligence model for accurate identification of medical conditions using immune repertoire

A Prediction Model Based on Machine Learning for Diagnosing the Early COVID-19 Patients

Interpretable Machine Learning for COVID-19: An Empirical Study on Severity Prediction Task

Disease diagnostics using machine learning of immune receptors

An interpretable machine learning framework for diagnosis and prognosis of COVID-19

Multi-omics and Immune Cells’ Profiling of COVID-19 Patients for ICU Admission Prediction: in Silico Analysis and an Integrated Machine Learning-Based Approach in the Framework of Predictive, Preventive, and Personalized Medicine

Recognition of Immune Cell Markers of COVID-19 Severity with Machine Learning Methods

An Explainable AI Approach for the Rapid Diagnosis of COVID-19 Using Ensemble Learning Algorithms

Identification and Validation of Prognostic Factors in Patients with COVID-19: A Retrospective Study Based on Artificial Intelligence Algorithms

Identifying Immune Infiltration by Deep Learning to Assess the Prognosis of Patients with Hepatocellular Carcinoma.

A Multi-Machine Learning Consensus Model Based on Clinical Features Reveals That Interleukin-10 Derived from Monocytes Leads to a Poor Prognosis in Patients with Coronavirus Disease-2019

ISMI-VAE: A deep learning model for classifying disease cells using gene expression and SNV data

Intelligent diagnosis of the severity of disease conditions in COVID-19 patients based on the LASSO method

A Generalizable and Easy-to-use COVID-19 Stratification Model for the Next Pandemic Via Immune-Phenotyping and Machine Learning

High-Accuracy and High-Throughput Reactive Lymphocyte Identification Using Lightweight Neural Networks

GACEMV: An ensemble learning framework for constructing COVID-19 diagnosis and prognosis models

A web visualization tool using T cell subsets as the predictor to evaluate COVID-19 patient's severity

Identifying MicroRNA Markers That Predict COVID-19 Severity Using Machine Learning Methods

AIRIVA: A Deep Generative Model of Adaptive Immune Repertoires

A Machine Learning Model for the Prediction of COVID-19 Severity Using RNA-Seq, Clinical, and Co-Morbidity Data